Secreted IL-1α promotes T-cell activation and expansion of CD11b+Gr1+ cells in carbon tetrachloride-induced liver injury in mice

European Journal of Immunology

Volumn 45, Issue 7, 2015, Pages 2084-2098

  Lin, Dandan ^a   Lei, Lei ^a   Zhang, Yinsheng ^a   Hu, Bo ^a   Bao, Guangming ^a   Liu, Yonghao ^a   Song, Yuan ^a   Liu, Chunliang ^a   Wu, Yan ^a   Zhao, Lixiang ^a   Yu, Xiao ^a   Liu, Haiyan ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Acute liver injury; CD11b+Gr1+ myeloid cells; Membrane IL 1 ; Secreted IL 1 ; T cell activation

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; CARBON TETRACHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; TOXIC HEPATITIS;

ANIMALS; ANTIGENS, CD11B; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; INTERLEUKIN-1ALPHA; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MYELOID CELLS; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 84935728529     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445195     Document Type: Article

References (70)

1. Taub, R., Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 2004. 5: 836-847.
2. Kershenobich Stalnikowitz, D. and Weissbrod, A. B., Liver fibrosis and inflammation. A review. Ann. Hepatol. 2003. 2: 159-163.
3. Rutherford, A. and Chung, R. T., Acute liver failure: mechanisms of hepatocyte injury and regeneration. Semin. Liver Dis. 2008. 28: 167-174.
4. Nowatari, T., Murata, S., Fukunaga, K. and Ohkohchi, N., Role of platelets in chronic liver disease and acute liver injury. Hepatol. Res. 2014. 44: 165-172.
5. Taniguchi, M., Takeuchi, T., Nakatsuka, R., Watanabe, T. and Sato, K., Molecular process in acute liver injury and regeneration induced by carbon tetrachloride. Life Sci. 2004. 75: 1539-1549.
6. Chen, P., Li, C., Pang, W., Zhao, Y., Dong, W., Wang, S. and Zhang, J., The protective role of Per2 against carbon tetrachloride-induced hepatotoxicity. Am. J. Pathol. 2009. 174: 63-70.
7. Poli, G., Liver damage due to free radicals. Br. Med. Bull. 1993. 49: 604-620.
8. Steinman, L., Martin, R., Bernard, C., Conlon, P. and Oksenberg, J. R., Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 2002. 25: 491-505.
9. Dinarello, C. A., Biologic basis for interleukin-1 in disease. Blood 1996. 87: 2095-2147.
10. Apte, R. N. and Voronov, E., Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol. Rev. 2008. 222: 222-241.
11. Dvorkin, T., Song, X., Argov, S., White, R. M., Zoller, M., Segal, S., Dinarello, C. A. et al., Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha. J. Leukoc. Biol. 2006. 80: 96-106.
12. Apte, R. N., Dotan, S., Elkabets, M., White, M. R., Reich, E., Carmi, Y., Song, X. et al., The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 2006. 25: 387-408.
13. Cohen, I., Rider, P., Carmi, Y., Braiman, A., Dotan, S., White, M. R., Voronov, E. et al., Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc. Natl. Acad. Sci. USA 2010. 107: 2574-2579.
14. Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S. et al., NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010. 464: 1357-1361.
15. Rajamaki, K., Lappalainen, J., Oorni, K., Valimaki, E., Matikainen, S., Kovanen, P. T. and Eklund, K. K., Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 2010. 5: e11765.
16. Sakurai, T., He, G., Matsuzawa, A., Yu, G. Y., Maeda, S., Hardiman, G. and Karin, M., Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 2008. 14: 156-165.
17. Tuncer, C., Oo, Y. H., Murphy, N., Adams, D. H. and Lalor, P. F., The regulation of T-cell recruitment to the human liver during acute liver failure. Liver Int. 2013. 33: 852-863.
18. Wu, Z., Han, M., Chen, T., Yan, W. and Ning, Q., Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int. 2010. 30: 782-794.
19. Holt, M. P., Cheng, L. and Ju, C., Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J. Leukoc. Biol. 2008. 84: 1410-1421.
20. Imamura, M., Ogawa, T., Sasaguri, Y., Chayama, K. and Ueno, H., Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 2005. 128: 138-146.
21. Karlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M. et al., Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009. 50: 261-274.
22. Zimmermann, H. W., Trautwein, C. and Tacke, F., Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol. 2012. 3: 56.
23. Jenkins, S. J., Ruckerl, D., Cook, P. C., Jones, L. H., Finkelman, F. D., vanRooijen, N., MacDonald, A. S. et al., Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011. 332: 1284-1288.
24. Tacke, F. and Kurts, C., Infiltrating monocytes versus resident Kupffer cells: do alternatively activated macrophages need to be targeted alternatively? Hepatology 2011. 54: 2267-2270.
25. Haverkamp, J. M., Crist, S. A., Elzey, B. D., Cimen, C. and Ratliff, T. L., In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur. J. Immunol. 2011. 41: 749-759.
26. Ostrand-Rosenberg, S. and Sinha, P., Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 2009. 182: 4499-4506.
27. Cripps, J. G., Wang, J., Maria, A., Blumenthal, I. and Gorham, J. D., Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology 2010. 52: 1350-1359.
28. Zhang, Y., Bi, Y., Yang, H., Chen, X., Liu, H., Lu, Y., Zhang, Z. et al., mTOR limits the recruitment of CD11b+Gr1+Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury. J. Leukoc. Biol. 2014. 95: 961-970.
29. Leifeld, L., Dumoulin, F. L., Purr, I., Janberg, K., Trautwein, C., Wolff, M., Manns, M. P. et al., Early up-regulation of chemokine expression in fulminant hepatic failure. J. Pathol. 2003. 199: 335-344.
30. Marra, F., DeFranco, R., Grappone, C., Parola, M., Milani, S., Leonarduzzi, G., Pastacaldi, S. et al., Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. J. Investig. Med. 1999. 47: 66-75.
31. Czaja, M. J., Geerts, A., Xu, J., Schmiedeberg, P. and Ju, Y., Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J. Leukoc. Biol. 1994. 55: 120-126.
32. Tumpey, T. M., Fenton, R., Molesworth-Kenyon, S., Oakes, J. E. and Lausch, R. N., Role for macrophage inflammatory protein 2 (MIP-2), MIP-1alpha, and interleukin-1alpha in the delayed-type hypersensitivity response to viral antigen. J. Virol. 2002. 76: 8050-8057.
33. dos Santos, D. C., Neves, P. C., Azeredo, E. L., Pelajo-Machado, M., Martinho, J. M., Pacheco-Moreira, L. F., Araujo, C. C. et al., Activated lymphocytes and high liver expression of IFN-gamma are associated with fulminant hepatic failure in patients. Liver Int. 2012. 32: 147-157.
34. Muntane, J., Montero, J. L., Lozano, J. M., Miranda-Vizuete, A., deLa Mata, M. and Mino, G., TNF-alpha but not IL-1alpha is correlated with PGE1-dependent protection against acute D-galactosamine-induced liver injury. Can. J. Gastroenterol. 2000. 14: 175-180.
35. Chen, M., Huang, W., Wang, C., Nie, H., Li, G., Sun, T., Yang, F. et al., High-mobility group box 1 exacerbates CCl(4)-induced acute liver injury in mice. Clin. Immunol. 2014. 153: 56-63.
36. Wesolowski, R., Markowitz, J. and Carson, W. E., 3rd, Myeloid derived suppressor cells-a new therapeutic target in the treatment of cancer. J. Immunother. Cancer 2013. 1: 10.
37. Zhu, R. Z., Xiang, D., Xie, C., Li, J. J., Hu, J. J., He, H. L., Yuan, Y. S. et al., Protective effect of recombinant human IL-1Ra on CCl4-induced acute liver injury in mice. World J. Gastroenterol. 2010. 16: 2771-2779.
38. Luckey, S. W. and Petersen, D. R., Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp. Mol. Pathol. 2001. 71: 226-240.
39. Alric, L., Orfila, C., Carrere, N., Beraud, M., Carrera, G., Lepert, J. C., Duffaut, M. et al., Reactive oxygen intermediates and eicosanoid production by kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4. Inflamm. Res. 2000. 49: 700-707.
40. Voronov, E., Dotan, S., Krelin, Y., Song, X., Elkabets, M., Carmi, Y., Rider, P. et al., Unique versus redundant functions of IL-1alpha and IL-1beta in the tumor microenvironment. Front Immunol. 2013. 4: 177.
41. Lotze, M. T., Deisseroth, A. and Rubartelli, A., Damage associated molecular pattern molecules. Clin. Immunol. 2007. 124: 1-4.
42. Rider, P., Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M. R. et al., IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation. J. Immunol. 2011. 187: 4835-4843.
43. Gross, O., Yazdi, A. S., Thomas, C. J., Masin, M., Heinz, L. X., Guarda, G., Quadroni, M. et al., Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 2012. 36: 388-400.
44. Rowell, D. L., Eckmann, L., Dwinell, M. B., Carpenter, S. P., Raucy, J. L., Yang, S. K. and Kagnoff, M. F., Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am. J. Physiol. 1997. 273: G322-G332.
45. Torre, D., Zeroli, C., Giola, M., Ferrario, G., Fiori, G. P., Bonetta, G. and Tambini, R., Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin. Infect Dis. 1994. 18: 194-198.
46. Kasprzak, A., Zabel, M., Wysocki, J., Seidel, J., Surdyk-Zasada, J. and Filipiak, B., Expression of mRNA for cytokines (TNF-alpha and IL-1alpha) in human cytomegalovirus (HCMV) and hepatitis B virus (HBV) infections. Folia Histochem. Cytobiol. 2002. 40: 63-68.
47. Steuerwald, N. M., Foureau, D. M., Norton, H. J., Zhou, J., Parsons, J. C., Chalasani, N., Fontana, R. J. et al., Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance. PLoS One 2013. 8: e81974.
48. Olteanu, S., Kandel-Kfir, M., Shaish, A., Almog, T., Shemesh, S., Barshack, I., Apte, R. N. et al., Lack of interleukin-1alpha in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice. Dig. Liver Dis. 2014. 46: 433-439.
49. Kamari, Y., Shaish, A., Vax, E., Shemesh, S., Kandel-Kfir, M., Arbel, Y., Olteanu, S. et al., Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J. Hepatol. 2011. 55: 1086-1094.
50. Song, X., Voronov, E., Dvorkin, T., Fima, E., Cagnano, E., Benharroch, D., Shendler, Y. et al., Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J. Immunol. 2003. 171: 6448-6456.
51. Khoruts, A., Osness, R. E. and Jenkins, M. K., IL-1 acts on antigen-presenting cells to enhance the in vivo proliferation of antigen-stimulated naive CD4 T cells via a CD28-dependent mechanism that does not involve increased expression of CD28 ligands. Eur. J. Immunol. 2004. 34: 1085-1090.
52. Klarnet, J. P., Kern, D. E., Dower, S. K., Matis, L. A., Cheever, M. A. and Greenberg, P. D., Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2. J. Immunol. 1989. 142: 2187-2191.
53. Gabrilovich, D. I., Ostrand-Rosenberg, S. and Bronte, V., Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012. 12: 253-268.
54. Serafini, P., Borrello, I. and Bronte, V., Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 2006. 16: 53-65.
55. Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M. P., Greten, T. F. et al., A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008. 135: 234-243.
56. Ma, S., Cheng, Q., Cai, Y., Gong, H., Wu, Y., Yu, X., Shi, L. et al., IL-17A produced by gammadelta T cells promotes tumor growth in hepatocellular carcinoma. Cancer Res. 2014. 74: 1969-1982.
57. Reyes-Gordillo, K., Segovia, J., Shibayama, M., Vergara, P., Moreno, M. G. and Muriel, P., Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim. Biophys. Acta. 2007. 1770: 989-996.
58. Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M. et al., Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. USA 1998. 95: 8222-8226.
59. Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T. S. and Chen, Y., IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 1998. 161: 6480-6486.
60. Yamamoto, M., Yoshizaki, K., Kishimoto, T. and Ito, H., IL-6 is required for the development of Th1 cell-mediated murine colitis. J. Immunol. 2000. 164: 4878-4882.
61. Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F. and Achong, M. K., IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 1998. 101: 311-320.
62. Cheng, L., Wang, J., Li, X., Xing, Q., Du, P., Su, L. and Wang, S., Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice. PLoS One 2011. 6: e17631.
63. Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V. and Taub, R., Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996. 274: 1379-1383.
64. Bansal, M. B., Kovalovich, K., Gupta, R., Li, W., Agarwal, A., Radbill, B., Alvarez, C. E. et al., Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression. J. Hepatol. 2005. 42: 548-556.
65. Kay, M. A., He, C. Y. and Chen, Z. Y., A robust system for production of minicircle DNA vectors. Nat. Biotechnol. 2010. 28: 1287-1289.
66. Koop, D. R., Inhibition of ethanol-inducible cytochrome P450IIE1 by 3-amino-1, 2, 4-triazole. Chem. Res. Toxicol. 1990. 3: 377-383.
67. Koop, D. R., Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol. Pharmacol. 1986. 29: 399-404.
68. Hu, B., Bao, G., Zhang, Y., Lin, D., Wu, Y., Wu, D. and Liu, H., Donor NK Cells and IL-15 promoted engraftment in nonmyeloablative allogeneic bone marrow transplantation. J. Immunol. 2012. 189: 1661-1670.
69. Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R. and Albelda, S. M., Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin. Cancer Res. 2005. 11: 6713-6721.
70. Vincent, J., Mignot, G., Chalmin, F., Ladoire, S., Bruchard, M., Chevriaux, A., Martin, F. et al., 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res. 2010. 70: 3052-3061.